Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era

Nicola Squillace,1 Giorgio Bozzi,2 Elisa Colella,1 Andrea Gori,2 Alessandra Bandera1 1Infectious Diseases Unit, Azienda Socio Sanitaria Territoriale di Monza, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy; 2Infectious Disease Unit, Department of Internal Medicine, Fondazione IRCC...

Полное описание

Библиографические подробности

Главные авторы:	Squillace N, Bozzi G, Colella E, Gori A, Bandera A
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Dove Medical Press 2018-10-01
Серии:	Drug Design, Development and Therapy
Предметы:	Protease inhibitors darunavir/cobicistat emtricitabine/tenofovir alafenamide HIV
Online-ссылка:	https://www.dovepress.com/darunavir-cobicistat-emtricitabine-tenofovir-alafenamide-safety-and-ef-peer-reviewed-article-DDDT
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!